Millennium Management’s scPharmaceuticals SCPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.05M | Buy |
538,470
+454,080
| +538% | +$1.73M | ﹤0.01% | 2641 |
|
|
2025
Q1 | $222K | Sell |
84,390
-25,519
| -23% | -$67.1K | ﹤0.01% | 3604 |
|
|
2024
Q4 | $389K | Sell |
109,909
-31,227
| -22% | -$111K | ﹤0.01% | 3398 |
|
|
2024
Q3 | $644K | Buy |
141,136
+11,066
| +9% | +$50.5K | ﹤0.01% | 3162 |
|
|
2024
Q2 | $566K | Sell |
130,070
-59,014
| -31% | -$257K | ﹤0.01% | 3155 |
|
|
2024
Q1 | $949K | Sell |
189,084
-167,789
| -47% | -$842K | ﹤0.01% | 2985 |
|
|
2023
Q4 | $2.24M | Sell |
356,873
-107,686
| -23% | -$675K | ﹤0.01% | 2393 |
|
|
2023
Q3 | $3.31M | Sell |
464,559
-751,647
| -62% | -$5.35M | ﹤0.01% | 2175 |
|
|
2023
Q2 | $12.4M | Sell |
1,216,206
-437,807
| -26% | -$4.46M | 0.01% | 1298 |
|
|
2023
Q1 | $15M | Buy |
1,654,013
+828,288
| +100% | +$7.51M | 0.01% | 1140 |
|
|
2022
Q4 | $5.92M | Buy |
825,725
+800,408
| +3,162% | +$5.74M | ﹤0.01% | 2007 |
|
|
2022
Q3 | $165K | Sell |
25,317
-10,899
| -30% | -$71K | ﹤0.01% | 4525 |
|
|
2022
Q2 | $175K | Buy |
36,216
+11,445
| +46% | +$55.3K | ﹤0.01% | 4508 |
|
|
2022
Q1 | $141K | Sell |
24,771
-8,567
| -26% | -$48.8K | ﹤0.01% | 4765 |
|
|
2021
Q4 | $167K | Sell |
33,338
-204
| -0.6% | -$1.02K | ﹤0.01% | 4742 |
|
|
2021
Q3 | $223K | Sell |
33,542
-24,175
| -42% | -$161K | ﹤0.01% | 4678 |
|
|
2021
Q2 | $353K | Buy |
+57,717
| New | +$353K | ﹤0.01% | 4429 |
|
|
2020
Q2 | – | Sell |
-35,059
| Closed | -$259K | – | 3711 |
|
|
2020
Q1 | $259K | Buy |
+35,059
| New | +$259K | ﹤0.01% | 2621 |
|
|
2019
Q3 | – | Sell |
-33,780
| Closed | -$108K | – | 3767 |
|
|
2019
Q2 | $108K | Buy |
+33,780
| New | +$108K | ﹤0.01% | 3328 |
|
|
2018
Q3 | – | Sell |
-19,300
| Closed | -$109K | – | 3736 |
|
|
2018
Q2 | $109K | Buy |
+19,300
| New | +$109K | ﹤0.01% | 3265 |
|
|
2018
Q1 | – | Sell |
-38,182
| Closed | -$462K | – | 3719 |
|
|
2017
Q4 | $462K | Buy |
+38,182
| New | +$462K | ﹤0.01% | 2906 |
|